In 2010, Purdue Pharma’s abuse-deterrent formulation of OxyContin ® was approved by the Food and Drug Administration (FDA). In the two years following its release, OxyContin ® related overdoses dropped 19 percent, but heroin overdose rose 23 percent, according to a recent study. Nevertheless, pharmaceutical companies are still moving forward with the development of abuse-deterrent drugs, with about 30 drugs being tested and the FDA has already approved three, including:
- Embeda ®, from Pfizer
- Targiniq ®, from Purdue
- Hysingla ®, from Purdue
“On the whole, society is better off having abuse-deterrent formulations. Focusing solely on what they don’t do is like saying seatbelts aren’t important because they don’t prevent all traffic fatalities. These products won’t stop all prescription drug abuse, but they’re a necessary part of the solution.”
No comments:
Post a Comment
Thanks for your comment!